These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6366988)

  • 21. [The basic treatment of rheumatoid arthritis. Current trends].
    Suţeanu S; Manuchian M
    Med Interne; 1984; 22(4):241-51. PubMed ID: 6393302
    [No Abstract]   [Full Text] [Related]  

  • 22. Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity.
    Gerber DA
    J Clin Invest; 1975 Jun; 55(6):1164-73. PubMed ID: 1079527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.
    Ward JR
    Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc sulfate in the treatment of rheumatoid arthritis.
    Job C; Menkes CJ; Delbarre F
    Arthritis Rheum; 1980 Dec; 23(12):1408-9. PubMed ID: 7458976
    [No Abstract]   [Full Text] [Related]  

  • 27. Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.
    Dixon JS; Pickup ME; Bird HA; Lee MR; Wright V; Downie WW
    Ann Rheum Dis; 1981 Oct; 40(5):480-8. PubMed ID: 6796009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugs.
    Astbury C; Platt R; Dixon JS; Le Gallez P; Hill J; Bird HA
    Br J Rheumatol; 1993 Jun; 32(6):467-73. PubMed ID: 8099519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.
    Lorber M; Aviram M; Linn S; Scharf Y; Brook JG
    Br J Rheumatol; 1985 Aug; 24(3):250-5. PubMed ID: 3860273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin.
    Franchimont P; Hauwaert C; Vanschoubroek K
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():75-82. PubMed ID: 6432417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of rheumatoid arthritis with oral zinc sulfate.
    Simkin PA
    Agents Actions Suppl; 1981; 8():587-96. PubMed ID: 6937133
    [No Abstract]   [Full Text] [Related]  

  • 33. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.
    Porter DR; Capell HA; Hunter J
    J Rheumatol; 1993 Apr; 20(4):645-9. PubMed ID: 8496858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature.
    Hartard C; Kunze K
    Eur Neurol; 1994; 34(6):337-40. PubMed ID: 7851456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.
    Tett SE; Day RO; Cutler DJ
    J Rheumatol; 1993 Nov; 20(11):1874-9. PubMed ID: 8308772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis. Practical use of medications.
    Furst DE
    Postgrad Med; 1990 Feb; 87(3):79-92. PubMed ID: 2406713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters.
    Bell CL
    Am J Med; 1983 Jul; 75(1A):46-51. PubMed ID: 6346870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum biochemistry in relation to the action of azathioprine in rheumatoid arthritis.
    Dixon JS; Bird HA; Sitton NG; Pickup ME; Leatham PA; Wright V
    Agents Actions; 1983 Jun; 13(4):373-9. PubMed ID: 6613752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.